This inventor holds 2 USPTO granted patents. Top assignees: Arch Development Corporation, Other. Active years: 2001.
Location History:
- Kobe, JP (2001)
- Chicago, IL (US) (2001)
Company Filing History:
1 out of 349 
1 out of 834,411 Years Active: 2001
Title: Innovations in Diabetes Research by Yukio Horikawa
Introduction
Yukio Horikawa is a notable inventor based in Kobe, Japan, recognized for his contributions to diabetes research. He holds 2 patents that focus on the genetic factors associated with diabetes, particularly type 2 diabetes. His work has significant implications for diagnostic and therapeutic applications in the field.
Latest Patents
Horikawa's latest patents include groundbreaking research on polynucleotides encoding calpain 10. This invention identifies genes responsible for non-insulin-dependent diabetes mellitus (NIDDM1) and demonstrates that the calpain 10 gene is linked to this condition. The invention also explores the potential for diagnosing type 2 diabetes through the analysis of mutations in calpain genes. Additionally, he has developed methods for treating diabetes based on the understanding that calpain mutations can lead to the disease.
Another significant patent involves the identification of mutations in diabetes susceptibility genes, including hepatocyte nuclear factor (HNF) 1 alpha, HNF1 beta, and HNF4 alpha. This invention highlights the MODY3, MODY4, and MODY1 loci, which correspond to the HNF1 alpha, HNF1 beta, and HNF4 alpha genes, respectively. The analysis of these mutations can serve as a diagnostic tool for diabetes, and the invention also proposes treatment methods based on these genetic insights.
Career Highlights
Throughout his career, Yukio Horikawa has made substantial contributions to the understanding of diabetes at a molecular level. His research has paved the way for new diagnostic and therapeutic strategies that can improve patient outcomes.
Collaborations
Horikawa has collaborated with prominent researchers in the field, including Graeme I. Bell and Nancy J. Cox. These collaborations have further enhanced the impact of his work on diabetes research.
Conclusion
Yukio Horikawa's innovative research and patents have significantly advanced the understanding of diabetes and its genetic underpinnings. His contributions continue to influence the development of diagnostic and therapeutic approaches in this critical area of health.